Evaluation of Health Canada’s Blood Research and Development Program 2017-18 to 2021-22 / prepared by the Office of Audit and Evaluation, Health Canada and the Public Health Agency of Canada. : H14-480/2022E-PDF
"This report presents the findings of the evaluation of the Blood Research and Development Program (BR&D) for the period from 2017-18 to 2021-22. The purpose of the evaluation was to examine the impact of activities of the Canadian Blood Services funded by Health Canada under the BR&D Program in supporting the safety of Canada’s blood supply system"--Executive summary, page ii.
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.931903&sl=1
| Ministère/Organisme | Canada. Health Canada, issuing body. Public Health Agency of Canada, issuing body. |
|---|---|
| Titre | Evaluation of Health Canada’s Blood Research and Development Program 2017-18 to 2021-22 / prepared by the Office of Audit and Evaluation, Health Canada and the Public Health Agency of Canada. |
| Variante du titre | Evaluation of the Blood Research and Development Program - September 2022 |
| Type de publication | Monographie |
| Langue | [Anglais] |
| Autres langues publiées | [Français] |
| Format | Électronique |
| Document électronique | |
| Note(s) | Issued also in French under title: Évaluation du Programme de recherche et de développement sur le sang de Santé Canada de 2017-2018 à 2021-2022. |
| Information sur la publication | [Ottawa] : Health Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, September 2022. |
| Description | 1 online resource (iii, 12 pages) : graphs |
| Numéro de catalogue |
|
| Descripteurs | Blood -- Collection and preservation -- Canada -- Safety measures -- Evaluation. Blood -- Research -- Canada -- Finance. |